Health ❯ Healthcare ❯ Medical Devices ❯ Continuous Glucose Monitoring

DexCom, Inc.

Brown Advisory Mid-Cap Growth Trails in Q3 as Portfolio Tilts to Secular Growth

The Q3 letter details new stakes in DraftKings, Carvana, alongside a valuation-driven exit from Figma.

Sands Capital’s Q3 Letter Highlights AI Drivers as Select Growth Lags Benchmark

Carillon Q3 Mid-Cap Growth Letter Highlights AI-Fueled Rally, Value’s Edge, and Three Pivotal Stock Updates